Clinical Trials Insight: 700027714

Trial Profile

Clinical Trials Insight: 700027714

Phase of Trial: Phase II

Latest Information Update: 17 Jun 2008

At a glance

  • Drugs Bismaltolatooxovanadium (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors Akesis Pharmaceuticals
  • Most Recent Events

    • 17 Jun 2008 Preliminary results presented in an Akesis Pharmaceuticals media release.
    • 04 Jun 2008 Status changed from recruiting to completed as reported by Akesis Pharmaceuticals.
    • 17 Mar 2008 Results for 4 patients have been reported in an Akesis Pharmaceuticals media release (see 9086466).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top